8604:TSENomura Holdings, Inc. Analysis
Data as of 2026-05-26 - not real-time
¥1,269.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Nomura Holdings is trading at ¥1,269, just above its 20‑day SMA of ¥1,263.7 and 50‑day SMA of ¥1,267.4, indicating a modest technical foothold. The RSI of 49.1 suggests the stock is neither overbought nor oversold, while a bullish MACD histogram (+2.74) points to short‑term upside momentum despite a neutral overall trend. Valuation metrics are attractive: a PE of 10.66 is well below the industry average of 16.75, and the price‑to‑book of 0.99 signals near‑book pricing, complemented by a solid dividend yield of 3.77% and a payout ratio under 45%. The upside/downside estimate of +18.5% aligns with analyst target prices averaging ¥1,503.75, implying a sizable upside potential.
Risk factors include a high 30‑day volatility of 35.45% and a recent decline in trading volume, which temper the bullish technical signals. The balance sheet shows a massive cash pile (~¥48.6 trn) that more than offsets the large debt (~¥35.3 trn), but operating cash flow remains negative, raising questions about cash generation sustainability. Overall, the stock appears undervalued with decent dividend income and growth prospects, but investors should monitor liquidity and cash‑flow trends.
Risk factors include a high 30‑day volatility of 35.45% and a recent decline in trading volume, which temper the bullish technical signals. The balance sheet shows a massive cash pile (~¥48.6 trn) that more than offsets the large debt (~¥35.3 trn), but operating cash flow remains negative, raising questions about cash generation sustainability. Overall, the stock appears undervalued with decent dividend income and growth prospects, but investors should monitor liquidity and cash‑flow trends.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD histogram
- Price near short‑term support levels
- Decreasing volume and high volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued PE relative to industry
- Projected upside of ~18.5% to target price
- Strong dividend yield with sustainable payout
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Robust cash reserves offsetting high debt
- Steady revenue growth of 27.5%
- Potential regulatory and cash‑flow headwinds
Key Metrics & Analysis
Financial Health
Revenue Growth27.50%
Profit Margin16.71%
P/E Ratio10.7
ROE10.07%
ROA0.63%
Debt/Equity917.37
P/B Ratio1.0
Op. Cash Flow¥-842960011264
Industry P/E16.8
Technical Analysis
TrendNeutral
RSI49.1
Support¥1,210.50
Resistance¥1,347.50
MA 20¥1,263.68
MA 50¥1,267.39
MA 200¥1,212.28
MACDBullish
VolumeDecreasing
Fear & Greed Index91.66
Valuation
Target Price¥1,503.75
Upside/Downside18.50%
GradeUndervalued
TypeBlend
Dividend Yield3.77%
Risk Assessment
Beta0.73
Volatility35.45%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.